Menú

GRenSSAP
GRenSSAP

Responsable del grupo
avatar_investigadors.jpg
Anna Berenguera Ossó
avatar_grups_recerca.png

Publicaciones

The impact of COVID-19 on population-level drug utilization of alendronate in five European databases

E. TAN, D. ROBINSON, A. JOEDICKE, M. SANCHEZ-SANTOS, M. MOSSEVELD, K. NIELSEN, C. REYES, A. VOSS, E. MARCONI, F. LAPI, J. REINOLD, K. VERHAMME, L. PEDERSEN, M. DE WILDE, M. RUIZ, M. ARAGON, P. BOSCO-LEVY, R. LASSALLE and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
The comparative risk of thrombosis with thrombocytopenia associated with different COVID-19 vaccines: International network cohort study including 5 European countries and the US

X. LI, E. BURN, T. DUARTE-SALLES, C. YIN, C. REICH, A. DELMESTRI, K. VERHAMME, P. RIJNBEEK and D. PRIETO-ALHAMBRA
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
Flecainide and risk of skin cancer: A large population-based case-control study in Spain and Denmark

C. REYES, L. LEON-MUNOZ, A. PISTILLO, S. SCHMIDT, K. KRISTENSEN, A. POTTEGARD, C. HUERTA, T. DUARTE-SALLES and D. PUENTE
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
Evaluating the comparative effectiveness and safety of repurposed drugs for COVID-19

E. TAN, D. DAWOUD, F. ARSHAD, J. LANE, J. WEAVER, T. DUARTE-SALLES, S. DUVALL, T. FALCONER, K. KOSTKA, K. LYNCH, M. MATHENY, C. REICH, P. RIJNBEEK, G. HRIPCSAK, M. SCHUEMIE, P. RYAN, D. PRIETO-ALHAMBRA and M. SUCHARD
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2022 Sep 1;

Ver más:
Venous or arterial thrombosis and deaths among COVID-19 cases: a European network cohort study

Burn E, Duarte-Salles T, Fernandez-Bertolin S, Reyes C, Kostka K, Delmestri A, Rijnbeek P, Verhamme K and Prieto-Alhambra D
LANCET INFECTIOUS DISEASES. 2022 Aug 1; . doi:10.1016/S1473-3099(22)00223-7; PMID:35576963

Ver más: